Withdrawn: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Bianca Hemmingsen; Jeppe B Schroll; Søren Lund; Jørn Wetterslev; Christian Gluud; Allan Vaag; David Peick Sonne; Lars Hyldborg Lundstrøm; Thomas Almdal

doi:10.1002/14651858.CD009008.pub2

Withdrawn: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Bianca Hemmingsen, Jeppe B Schroll, Søren Lund, Jørn Wetterslev, Christian Gluud, Allan Vaag, David Peick Sonne, Lars Hyldborg Lundstrøm, Thomas Almdal

61 Citations (Scopus)

Abstract

Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

Original language	English
Journal	Cochrane Database of Systematic Reviews
Volume	4
Pages (from-to)	CD009008
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD009008.pub2
Publication status	Published - 2013

Access to Document

10.1002/14651858.CD009008.pub2

Cite this

@article{c2c5a9c9cdbb43908d580ca64828ab04,

title = "Withdrawn: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus",

abstract = "Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.",

author = "Bianca Hemmingsen and Schroll, \{Jeppe B\} and S{\o}ren Lund and J{\o}rn Wetterslev and Christian Gluud and Allan Vaag and Sonne, \{David Peick\} and Lundstr{\o}m, \{Lars Hyldborg\} and Thomas Almdal",

year = "2013",

doi = "10.1002/14651858.CD009008.pub2",

language = "English",

volume = "4",

pages = "CD009008",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Withdrawn: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

AU - Hemmingsen, Bianca

AU - Schroll, Jeppe B

AU - Lund, Søren

AU - Wetterslev, Jørn

AU - Gluud, Christian

AU - Vaag, Allan

AU - Sonne, David Peick

AU - Lundstrøm, Lars Hyldborg

AU - Almdal, Thomas

PY - 2013

Y1 - 2013

N2 - Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

AB - Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

UR - https://www.scopus.com/pages/publications/84880656964

UR - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009008.pub3/full

U2 - 10.1002/14651858.CD009008.pub2

DO - 10.1002/14651858.CD009008.pub2

M3 - Journal article

C2 - 23633364

SN - 1469-493X

VL - 4

SP - CD009008

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Withdrawn: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Abstract

Access to Document

Other files and links

Fingerprint

Cite this